North Brunswick, NJ · Founded 2020 · Privately Held (backing)
Developer of a precision exposome medicine platform designed to analyze the molecular impact of environmental exposures on health. LinusBio is based in North Brunswick, NJ and was founded in 2020. Its last reported valuation was $171 million in Jul 2024. It has raised $34.6 million.
Last reported valuation
$171.2M
Oct 2026
Priced at
—
Total raised
$34.6M
Last round
—
No prints on record
No secondary trades in LinusBio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of LinusBio with a free account
·Watch LinusBio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of LinusBio stock.
